Intestinal epithelial cell-specific CD98 expression regulates tumorigenesis in Apc Min/mice

Laboratory Investigation

Volumn 92, Issue 8, 2012, Pages 1203-1212

  Nguyen, Hang Thi Thu ^a,b   Dalmasso, Guillaume ^a,b   Yan, Yutao ^a   Laroui, Hamed ^a   Charania, Moiz ^a   Ingersoll, Sarah ^a,c   Ayyadurai, Saravanan ^a   Zhang, Yuchen ^a   Sitaraman, Shanthi ^d   Merlin, Didier ^a,c  

^a GEORGIA STATE UNIVERSITY   (United States)

^b CRNH Auvergne   (France)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adenomatous polyposis coli; CD98; intestinal epithelia; tumorigenesis

Indexed keywords

APC PROTEIN; BETA CATENIN; CD98 ANTIGEN; CHEMOKINE; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; COLON ADENOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; INTESTINE EPITHELIUM CELL; INTESTINE TUMOR; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; VALIDATION PROCESS; WNT SIGNALING PATHWAY;

EID: 84864452209     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.83     Document Type: Article

References (29)

1. Fenczik CA, Sethi T, Ramos JW, et al. Complementation of dominant suppression implicates CD98 in integrin activation. Nature 1997; 390:81-85.
2. Feral CC, Nishiya N, Fenczik CA, et al. CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci USA 2005;102:355-360.
3. Merlin D, Sitaraman S, Liu X, et al. CD98-mediated links between amino acid transport and beta 1 integrin distribution in polarized columnar epithelia. J Biol Chem 2001;276:39282-39289.
4. Esteban F, Ruiz-Cabello F, Concha A, et al. Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx. Cancer 1990;66:1493-1498.
5. Esseghir S, Reis-Filho JS, Kennedy A, et al. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J Pathol 2006;210:420-430.
6. Prager GW, Poettler M, Schmidinger M, et al. CD98hc (SLC3A2), a novel marker in renal cell cancer. Eur J Clin Invest 2009;39:304-310.
7. Kaira K, Oriuchi N, Imai H, et al. l-Type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci 2008;99:2380-2386.
8. Nguyen HT, Dalmasso G, Torkvist L, et al. CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice. J Clin Invest 2011;121:1733-1747.
9. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:1276-1299.
10. Laken SJ, Papadopoulos N, Petersen GM, et al. Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci USA 1999;96:2322-2326.
11. Oshima M, Oshima H, Kitagawa K, et al. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 1995;92:4482-4486.
12. Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256:668-670.
13. Rubinfeld B, Albert I, Porfiri E, et al. Binding of GSK3beta to the APCbeta-catenin complex and regulation of complex assembly. Science 1996;272:1023-1026.
14. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997;275:1784-1787.
15. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
16. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96:5522-5527.
17. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
18. Flint N, Cove FL, Evans GS. A low-temperature method for the isolation of small-intestinal epithelium along the crypt-villus axis. Biochem J 1991;280(Pt 2):331-334.
19. Nguyen HT, Dalmasso G, Yan Y, et al. MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J Biol Chem 2010;285:1479-1489.
20. Nguyen HT, Dalmasso G, Yan Y, et al. Ecto-phosphorylation of CD98 regulates cell-cell interactions. PLoS One 2008;3:e3895.
21. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996;93: 8455-8459.
22. Le Floch N, Rivat C, De Wever O, et al. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling. FASEB J 2005;19:144-146.
23. Sears R, Nuckolls F, Haura E, et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000;14:2501-2514.
24. Sears RC. The life cycle of C-myc: from synthesis to degradation. Cell Cycle 2004;3:1133-1137.
25. Vervoorts J, Luscher-Firzlaff J, Luscher B. The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 2006;281: 34725-34729.
26. Lee SH, Hu LL, Gonzalez-Navajas J, et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med 2010;16:665-670.
27. Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology 2010;138:2101-2114 e2105.
28. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124:823-835.
29. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-867.